Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02276547 · ClinicalTrials.gov registry record · NA
Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System
A NA study of Mitral Valve Regurgitation, sponsored by Shockwave Medical.
- Active
- Registry status
- NA
- Development phase
- 27
- Enrollment target
- 10
- Study locations
NCT02276547: Active NA study of Mitral Valve Regurgitation, sponsored by Shockwave Medical.
NCT02276547 is a NA study of Mitral Valve Regurgitation that is active but no longer recruiting, run by Shockwave Medical. The registered enrollment target is 27 participants, below the 812-participant average among 11 other Mitral Valve Regurgitation trials with a reported enrollment target (97% lower). The trial reports 10 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02276547, a NA study of Mitral Valve Regurgitation, is active but no longer recruiting, sponsored by Shockwave Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
- 10
- Study locations
Study Summary
The purpose of this study is to evaluate the safety and initial performance of the Neovasc Tiara Mitral Transcatheter Heart Valve with the Tiara Transapical Delivery System.
Primary Outcome
Defined as disabling stroke, myocardial infarction, renal failure requiring dialysis, life-threatening bleeding, and cardiac surgical or transcatheter reintervention
Conditions Studied
Interventions
- DEVICE Mitral valve replacement
Study Locations (10)
California
- Cedars Sinai Medical Center - Los Angeles
Illinois
- Northwestern University - Chicago
Michigan
- Henry Ford Health System - Detroit
Missouri
- Washington University - St Louis
New York
- Columbia University Medical Center - New York
Washington
- University of Washington Medical Center - Seattle
Other
- ZNA Middelheim - Antwerp
Alberta
- University of Alberta - Edmonton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2014-12 |
| Est. Completion | 2025-08 |
| Phase | NA |
What the registry record for NCT02276547 still lists
NCT02276547 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 812-participant average among 11 other Mitral Valve Regurgitation trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Mitral Valve Regurgitation appearing as the primary indexed condition, and to 1 intervention - of which Mitral valve replacement is the first listed.
NCT02276547 lists 10 locations in 10 states (California, Illinois, Michigan).
Frequently Asked Questions
What is clinical trial NCT02276547 about?
NCT02276547 is a clinical study titled "Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System". The purpose of this study is to evaluate the safety and initial performance of the Neovasc Tiara Mitral Transcatheter Heart Valve with the Tiara Transapical Delivery System.
What is the current status of trial NCT02276547?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 27 participants. The study started on 2014-12. Estimated completion is 2025-08.
What conditions does trial NCT02276547 study?
This clinical trial studies the following conditions: Mitral Valve Regurgitation.
What interventions are being tested in trial NCT02276547?
The interventions under investigation include: Mitral valve replacement (DEVICE).
Who is sponsoring clinical trial NCT02276547?
This trial is sponsored by Shockwave Medical, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02276547 being conducted?
This trial has 10 study locations across California, Illinois, Michigan, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mitral Valve Regurgitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02276547's enrollment target sits among peer trials
27 11th of 11 higher than 1 of 11 other Mitral Valve Regurgitation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mitral Valve Regurgitation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)
RECRUITING · NA
-
AltaValve Pivotal Trial
RECRUITING · NA
-
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
RECRUITING · NA
-
PARTNER 3 Trial - Mitral Valve in Valve
ACTIVE NOT RECRUITING · NA
-
MitraClip REPAIR MR Study
ACTIVE NOT RECRUITING · NA
-
Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional MR
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia